INFLAMMATORY MYOPATHY
Clinical trials for INFLAMMATORY MYOPATHY explained in plain language.
Never miss a new study
Get alerted when new INFLAMMATORY MYOPATHY trials appear
Sign up with your email to follow new studies for INFLAMMATORY MYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for muscle disease: drug trial launches
Disease control Not yet recruitingThis study tests a drug called telitacicept in 30 adults with inflammatory myopathy, a condition where the immune system attacks muscles. The goal is to see if the drug is safe and can control the disease. Participants must have not responded well to standard treatments like ster…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE2, PHASE3 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated May 04, 2026 16:23 UTC
-
Could immune reset with donor CAR T-Cells tame lupus?
Disease control Not yet recruitingThis early-phase study tests a universal (donor-derived) CAR T-cell therapy called QT-019C in 15 adults with lupus or inflammatory myositis that has not responded to standard treatments. The therapy targets two immune-cell markers (CD19 and BCMA) to reset the faulty immune system…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: EARLY_PHASE1 • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated May 01, 2026 15:57 UTC